Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 67Colorectal Neoplasms 36Central Nervous System Neoplasms 36Colonic Neoplasms 34Rectal Neoplasms 32Glioblastoma 23Gliosarcoma 20Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 18Stomach Neoplasms 16Pancreatic Neoplasms 15Sarcoma 14Ovarian Neoplasms 13Head and Neck Neoplasms 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Melanoma 11Astrocytoma 11Esophageal Neoplasms 10Carcinoma, Ovarian Epithelial 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Fallopian Tube Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8Liver Neoplasms 7

Interventions

Surgical Procedures, Operative 1Fluorouracil 1Drug Therapy 1Cisplatin 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Localized Resectable Adult Primary Liver Cancer × Chemotherapy, Adjuvant × Clear all
NCT00238160 2013-05-30

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 3 Withdrawn

Localized Resectable Adult Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡